AEterna Zentaris News

Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending

Benzinga22minutes ago

AEterna Zentaris To Carry Out 1-for-4 Reverse Stock Split On May 3rd, 2024

May 2nd - $AEterna Zentaris(AEZS.US)$ is about to implement a 1-for-4 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from May 3rd, 2024.$AEterna Zentaris(AEZS.U

moomoo NewsMay 1 19:40 ET

Aeterna Zentaris Announces Share Consolidation

TipRanksMay 1 17:27 ET

Aeterna Zentaris Initiates Major Share Consolidation

TipRanksMay 1 09:34 ET

Express News | Aeterna Zentaris Announced That It Has Filed Articles Of Amendment To Effect The Previously Announced Share Consolidation (or Reverse Stock Split) Of Its Issued And Outstanding Common Shares

BenzingaMay 1 07:58 ET

12 ChatGPT Penny Stock Picks Right Now

Yahoo FinanceApr 28 12:01 ET

Aeterna Zentaris Announces Merger Approval

TipRanksMar 28 11:59 ET

AEterna Zentaris and Ceapro Anticipate Completing the Transaction in the 2Q of 2024 >AEZS

AEterna Zentaris and Ceapro Anticipate Completing the Transaction in the 2Q of 2024 >AEZS

Dow JonesMar 28 07:56 ET

Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris AEZS

Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris AEZS

Dow JonesMar 28 07:55 ET

Aeterna Zentaris Financials Affirm Compliance

TipRanksMar 27 11:30 ET

Aeterna Zentaris Completes Trial Enrollment, Plans Merger

TipRanksMar 27 08:51 ET

Aeterna Zentaris Reports Q4 Results

Seeking AlphaMar 27 08:18 ET

AEterna Zentaris Q4 2023 GAAP EPS $(1.16) Misses $(0.97) Estimate, Sales $100.000K Down From $2.485M YoY

AEterna Zentaris (NASDAQ:AEZS) reported quarterly losses of $(1.16) per share which missed the analyst consensus estimate of $(0.97) by 19.59 percent. The company reported $100.000 thousand in sales

BenzingaMar 27 08:10 ET

Aeterna Zentaris Brief: Reporting Q4 Net Loss of US$5.6 Million, or $1.16 Loss per Common Share

08:07 AM EDT, 03/27/2024 (MT Newswires) -- Aeterna Zentaris Brief: Reporting Q4 Net Loss of US$5.6 million, or $1.16 loss per common share

MT NewswiresMar 27 08:07 ET

Aeterna Zentaris Brief: Announcing Completion of Enrollment in Ongoing Pivotal DETECT-Trial for Diagnosis of Childhood-Onset Growth Hormone Deficiency

08:07 AM EDT, 03/27/2024 (MT Newswires) -- Aeterna Zentaris Brief: Announcing Completion of Enrollment in Ongoing Pivotal DETECT-Trial for Diagnosis of Childhood-Onset Growth Hormone Deficiency

MT NewswiresMar 27 08:07 ET

AEterna Zentaris 4Q Loss/Shr $1.16 >AEZS

AEterna Zentaris 4Q Loss/Shr $1.16 >AEZS

Dow JonesMar 27 08:06 ET

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

Dow JonesMar 12 14:10 ET

ISS Endorses Aeterna Zentaris-Ceapro Merger

TipRanksFeb 26 08:18 ET

Ceapro Brief: Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR Arrangement Agreement to Approve Merger of Equals to Create a Diversified Biopharmaceutical Co

07:31 AM EST, 02/26/2024 (MT Newswires) -- Ceapro Brief: Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR Arrangement Agreement to Approve Merger of

MT NewswiresFeb 26 07:31 ET

Aeterna Zentaris Files to Sell 2.53M Warrants

Seeking AlphaFeb 15 17:33 ET